{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:18:28Z","timestamp":1777897108765,"version":"3.51.4"},"reference-count":19,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>Background: Methadone and buprenorphine are the 2 opiate maintenance treatments (OMTs) available in France. According to good clinical practices, a full clinical and biological assessment is required before deciding to initiate or renew an OMT. For methadone, this assessment includes psychoactive drug consumption investigation through an initial interview completed by a systematic urine test mandatory before starting methadone treatment. In case of buprenorphine prescription, the situation is less clear and the urine test was not systematically performed. This work aims at evaluating changes in the therapeutic strategy brought by the systematic use of urine strips for detecting drug consumptions. Methods: During 1\u00a0month, for each case of OMT renewal, physicians belonging to the 3 types of prescribing structures in France (general medicine, specialized centers for drug addict patients, and specialized centers for drug addict patients in prison) had to complete a specific questionnaire about prescription renewal. This questionnaire contained 2 parts. The first part was completed by the physicians before the urine test strip realization. The second part was completed by the same physicians at the end of the consultation, after obtaining the results from the urine test strip. A change between parts 1 and 2 of the questionnaire concerning OMT prescription, dialogue with the patient, associated psychotropic drug prescription, and orientation were considered as a change in therapeutic strategy. Results: A total of 429 questionnaires have been collected. Among them, 315 showed at least 1 change in therapeutic strategy (73.4%). Conclusions: This study highlighted the important benefits brought by the urine test strip in managing patients under opiate maintenance treatment. Urine test strips provided an immediate answer that allowed physicians to optimize their therapeutic strategy. However, regulatory evolutions would be necessary to ease their implantation.<\/jats:p>","DOI":"10.1080\/08897077.2016.1176979","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T14:25:09Z","timestamp":1461075909000},"page":"584-590","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of Psychotropic Drug Urine Test Strips in Opiate Maintenance Therapy: A Clinical Assessment of its Advantages"],"prefix":"10.1177","volume":"37","author":[{"given":"Caroline","family":"Victorri-Vigneau","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France"},{"name":"EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Rousselet","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France"},{"name":"EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France"},{"name":"Department of Addictology, Nantes University Hospital, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Grall-Bronnec","sequence":"additional","affiliation":[{"name":"EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France"},{"name":"Department of Addictology, Nantes University Hospital, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regis","family":"Bouqui\u00e9","sequence":"additional","affiliation":[{"name":"EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France"},{"name":"Department of Clinical Pharmacology, Nantes University Hospital, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeric","family":"Belliot","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryl\u00e8ne","family":"Guerlais","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Guillet","sequence":"additional","affiliation":[{"name":"Nantes Addictology Network, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Jolliet","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Center for Evaluation and Information on Pharmacodependence, Nantes University Hospital, Nantes, France"},{"name":"EA4275 Biostatistics, Pharmacoepidemiology and Subjective Measures in Health Science, Nantes University, Nantes, France"},{"name":"Department of Clinical Pharmacology, Nantes University Hospital, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"bibr1-08897077.2016.1176979","unstructured":"Agence Nationale d'Accr\u00e9ditation et d'Evaluation en Sant\u00e9 (ANAES). Strat\u00e9gies th\u00e9rapeutiques pour les personnes d\u00e9pendantes des opiac\u00e9s: place des traitements de substitution. Conf\u00e9rence de consensus. 2004. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/TSO_court.pdf"},{"key":"bibr2-08897077.2016.1176979","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9 (AFSSAPS)- Agence Nationale d'Accr\u00e9ditation et d'Evaluation en Sant\u00e9 (ANAES). R\u00e9duire les mauvaises utilisations des m\u00e9dicaments de substitution des opiac\u00e9s. Recommandations professionnelles. 2004. http:\/\/www.sanpsy.univ-bordeauxsegalen.fr\/data\/documents\/cours_addicto\/mauvaises_utilisation_anaes_2004.pdf"},{"key":"bibr3-08897077.2016.1176979","unstructured":"Direction G\u00e9n\u00e9rale de la Sant\u00e9 (DGS). Circulaire DGS\/SP3\/95 N\u00b029 du 31 mars 1995 relative au traitement de substitution pour les toxicomanes d\u00e9pendants aux opiac\u00e9s. 1995. http:\/\/bdoc.ofdt.fr\/doc_num.php?explnum_id=20611"},{"key":"bibr4-08897077.2016.1176979","unstructured":"Direction G\u00e9n\u00e9rale de la Sant\u00e9 (DGS). Circulaire DGS\/DHOS N\u00b02002\/57 du 30 janvier 2002 relative \u00e0 la prescription de la m\u00e9thadone par les m\u00e9decins exer\u00e7ant en \u00e9tablissement de sant\u00e9, dans le cadre de l'initialisation d'un traitement de substitution pour les toxicomanes d\u00e9pendants majeurs aux opiac\u00e9s. 2002. http:\/\/pmb.ofdt.fr\/documents_numeriques\/LEGI\/232.pdf"},{"key":"bibr5-08897077.2016.1176979","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9 (AFSSAPS). Initiation et suivi du traitement substitutif de la pharmacod\u00e9pendance majeure aux opiac\u00e9s par bupr\u00e9norphine haut dosage. Mise au point. 2011. http:\/\/www.ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/8439b6cbb654338f7dcd945b2d1f070e.pdf"},{"key":"bibr6-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1080\/09595230410001704208"},{"key":"bibr7-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1159\/000336540"},{"key":"bibr8-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.11.006"},{"key":"bibr9-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2012064"},{"key":"bibr10-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.05.015"},{"key":"bibr11-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2009043"},{"key":"bibr12-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/7\/2\/026006"},{"key":"bibr13-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.11.2502"},{"key":"bibr14-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2013020"},{"key":"bibr15-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.05.001"},{"issue":"214","key":"bibr16-08897077.2016.1176979","first-page":"28","author":"Piralishvili G","year":"2013","journal-title":"Georgian Med News."},{"key":"bibr17-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.52964\/AMJA.0285"},{"key":"bibr18-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bks063"},{"key":"bibr19-08897077.2016.1176979","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.20466"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2016.1176979","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2016.1176979","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2016.1176979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:47:30Z","timestamp":1777625250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2016.1176979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1080\/08897077.2016.1176979"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2016.1176979","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}